A Comparison of One-site and Two-site Peribulbar Anaesthesia for Cataract Surgery at Kaduna, Nigeria

March 15, 2015 updated by: National Eye Centre, Kaduna

A Comparison of One-site and Two-site Peribulbar Anaesthesia for Cataract Surgery at National Eye Centre, Kaduna. Nigeria

The aim of the study was to compare the efficacy and safety of single injection peribulbar anaesthesia against the classic double injection technique.

This was a double blind randomized controlled trial involving two groups of consenting, adult Nigerian subjects with operable age-related cataract. An anaesthetic nurse who allocated the subjects to the two groups administered all the injections. The same surgeon operated on all the subjects while the principal investigator and a research assistant measured the outcome variables. All others were blinded as to subject allocation.

Study Overview

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kaduna, Nigeria, 800001
        • National Eye Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 50 years and above
  • Diagnosed with uncomplicated senile cataract
  • Visual acuity of <3/60

Exclusion Criteria:

  • Impaired mental status
  • Difficulty in speaking
  • Known allergy to amide-type local anaesthetic agents and/ or hyaluronidase
  • Previous surgery in the same eye
  • Glaucoma
  • Impaired ocular motility
  • Eyelid abnormalities
  • Patients with only one eye

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: One-site peribulbar injection
Injection of a mixture of lidocaine 2% + adrenaline 0.125mg/ml + hyaluronidase 15 International Units (IU)/ml into the inferior medial orbital compartment
injection into the inferior medial orbital compartment
ACTIVE_COMPARATOR: Two-site peribulbar injection
Injection of a mixture of lidocaine 2% + adrenaline 0.125mg/ml + hyaluronidase 15IU/ml into the infero-temporal and supero-nasal orbital compartments
Two injections into the infero-temporal and supero-nasal orbital compartments

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time Taken to Achieve Adequate Akinesia
Time Frame: 10 minutes and 15 minutes
Time taken to achieve akinesia and anesthesia adequate for surgery. Ability to move the eye in each of four directions (up, down, right and left) was scored thus: 2- normal movement, 1- reduced movement and 0- flicker or no movement. Upper eyelid akinesia was scored as 2- normal opening, 1- reduced movement and 0- complete immobility. Maximum score of 10 and minimum of 0. Adequate akinesia was defined as a total score of <4 and was evaluated at 10 and 15 minutes.
10 minutes and 15 minutes
Supplementary Injection(s)
Time Frame: 5 minutes
After 10 minutes if akinesia score was more than 3, supplementary injections were given and the effect assessed was 5 minutes later
5 minutes
Complications of Local Anaesthetic Injection
Time Frame: 0,10 and 15 minutes

Systemic complications: dyspnoea, bronchospasm, impaired consciousness, intravascular injection etc

Local complications: eyelid oedema, corneal oedema, conjunctival chemosis, conjunctival haemorrhage, globe perforation, vitreous haemorrhage, orbital haemorrhage etc

0,10 and 15 minutes
Pain Score for Local Anaesthetic Injection
Time Frame: 20 minutes
Pain was scored using a 4 point scale: 1 - no pain, 2 - mild pain, 3 - moderate pain, 4 - severe pain
20 minutes
Pain Score for Cataract Surgery
Time Frame: 20 minutes
Pain was scored on a 4 point scale: 1 - no pain, 2 - mild pain, 3 - moderate pain, 4 - severe pain
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Volume of Anaesthetic Drug (ml)
Time Frame: 10 and 15 minutes
Total volume of anaesthetic drug injected into the orbit to achieve anaesthesia and akinesia adequate for cataract surgery
10 and 15 minutes
Total Number of Injections
Time Frame: 15 minutes
Total number of injections required to achieve an akinesia score of <4
15 minutes
Surgeon Satisfaction Score for Local Anaesthetic Block
Time Frame: 20 minutes
Surgeon subjectively scored satisfaction with the anaesthetic block on a 4 point scale: 1- poor (25%), 2 - fair (50%), 3 - good (75%), 4 - excellent (100%)
20 minutes
Acceptability of the Anaesthetic Block to the Subject
Time Frame: 25 minutes
Subjects were asked if they would agree to have the same anaesthetic procedure the next time they needed cataract surgery in the other eye
25 minutes
Duration of Cataract Surgery (Minutes)
Time Frame: At the end of surgery
Time interval from conjunctival incision to application of eye pad
At the end of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aminatu A AbdulRahman, MBBS, FWACS, National Eye Centre, Kaduna
  • Study Chair: Mahmoud B Alhassan, MBBS, FWACS, National Eye Centre, Kaduna

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (ACTUAL)

December 1, 2012

Study Completion (ACTUAL)

June 1, 2013

Study Registration Dates

First Submitted

May 26, 2014

First Submitted That Met QC Criteria

May 26, 2014

First Posted (ESTIMATE)

May 29, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

March 17, 2015

Last Update Submitted That Met QC Criteria

March 15, 2015

Last Verified

May 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NECKAD/TRIALS/001/2012

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anaesthesia

Clinical Trials on One-site peribulbar injection

Subscribe